Signaling Pathways - Dihydroorotate dehydrogenase - p53-MDM2 interaction - RSK - Farnesoid X receptors (FXRs)
清除全部
- B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂
- B4888 Obeticholic Acid2 Citation中文名: 奥贝胆酸Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B3392 GSK269962ATarget: ROCK|RSK|MSKSummary: ROCK抑制剂
- B1528 XL335Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂
- B1850 Teriflunomide中文名: 特立氟胺Target: Dihydroorotate dehydrogenaseSummary: 二氢乳清酸脱氢酶的抑制剂
- A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂
- A2005 Nutlin-3bTarget: p53-MDM2 interactionSummary: MDM2/p53抑制剂